31.08.2010
- Genzyme rejected an $18.5 billion takeover offer from French drugmaker Sanofi-Aventis, saying it dramatically undervalues the company. The Cambridge, Massachusetts-based...
30.08.2010
- France's Sanofi-Aventis on Sunday publicly disclosed its $18.5 billion, $69-per-share cash offer for Genzyme in a bid to rouse shareholders after failing to engage the U.S...
26.08.2010
- Sanofi-Aventis shareholders L'oreal and Total worry that the French drugmaker will pay too much for U.S. biotech company Genzyme and are not convinced it is the best fit, bankers...
26.08.2010
- Sanofi-Aventis is not willing to pay more than $70 per share for U.S. biotech Genzyme and may look at alternative targets, Bloomberg reported on Wednesday, citing sources familiar...
24.08.2010
- U.S. biotechnology firm Genzyme and its French suitor Sanofi-Aventis are at odds over the threshold price at which Sanofi could begin the due diligence on Genzyme's books, the Wall...
23.08.2010
- The lack of new information about Sanofi Aventis' reported interest in acquiring Genzyme could mean the two sides have begun talks, according to Sanford Bernstein analyst Geoffrey...
30.07.2010
- Sanofi-Aventis Chief Executive Chris Viehbacher delivered forecast-beating second quarter results onThursday as he prepared to bid $18.7 billion for U.S biotech group Genzyme...
